Itamione

Diclofenac Sodium, the active ingredient in Itamione, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a topical formulation for cutaneous use. It is commonly prescribed to relieve pain and reduce inflammation associated with musculoskeletal disorders, inflammatory conditions, and various forms of arthritis in adult patients. The medication is intended for external application to the affected area, providing localized action while minimizing systemic exposure.

GNH USA supplies Itamione as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Diclofenac Sodium is a topical NSAID that reduces inflammation and pain in musculoskeletal and joint disorders.

Musculoskeletal pain: alleviates pain and improves mobility in affected muscles and tendons. Inflammatory conditions: diminishes local swelling and tenderness. Arthritis: eases joint stiffness and discomfort.

Topical diclofenac may cause a range of local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation at the application site - Burning or stinging sensation - Pruritus (itching) - Redness (erythema)

Serious or Rare Side Effects: - Allergic dermatitis or urticaria - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Systemic hypersensitivity reactions such as anaphylaxis - Hepatotoxicity (rare)

When using Itamione, several precautions should be observed to ensure safety and optimal therapeutic outcome.

- Avoid application on broken or infected skin: apply only to intact epidermis. - Do not use with other topical NSAIDs: risk of additive irritation. - Limit treatment duration to the period recommended by the prescriber: typically no longer than 7‑14 days. - Caution in patients taking systemic anticoagulants or antiplatelet agents: monitor for increased bleeding. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Diclofenac sodium can interact with other medicines, altering its safety profile or therapeutic effect.

Major Interactions (Avoid): - Concurrent oral NSAIDs: increased risk of gastrointestinal bleeding and systemic toxicity. - Anticoagulants (e.g., warfarin, heparin): heightened bleeding tendency. - Lithium therapy: diclofenac may raise lithium serum concentrations. - Methotrexate: risk of enhanced methotrexate toxicity.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): possible reduction in renal function. - ACE inhibitors or ARBs: may impair renal perfusion when combined. - SSRIs or SNRIs: modest increase in bleeding risk. - Corticosteroids: additive risk of skin thinning and ulceration.